Home ProductsCancer Treatment Steroids

566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane

566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane

    • 566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane
    • 566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane
  • 566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane

    Product Details:

    Place of Origin: China
    Brand Name: FuLu
    Certification: ISO9001
    Model Number: 566-48-3

    Payment & Shipping Terms:

    Minimum Order Quantity: Negotiable
    Price: Negotiable
    Packaging Details: 1kg Sterile aluminum foil bag or discreet and tight safe packing for Customs pass guaranteed
    Delivery Time: Within 24h after payment
    Payment Terms: , MoneyGram, T/T, Bit-coin
    Supply Ability: Mass stock
    Contact Now
    Detailed Product Description
    Chemical Name: 4-hydroxy-androst-4-ene-17-dione MF: C19H26O3
    MW: 302.41 Function: For Breast Cancer
    Product Name: Formestane CAS: 566-48-3
    High Light:

    steroids cancer treatment

    ,

    prohormones bodybuilding

    566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane

     

    Quack detail

     

    Product name Formestane
    Trade name Lentaron
    Chemical name 4-hydroxy-androst-4-ene-17-dione
    CAS 566-48-3
    MF C19H26O3
    MW 302.41
    Catalogy aromatase inhibitor steroid
    mp 199-202°C
    Usage As a aromatase inhibitor,used in breast cancer or bodybuilding anti-estrogen
    Appearance off-white crystalline powder

     

    Application


    Formestane is a second generation, irreversible, steroidal aromatase inhibitor. It inhibits the aromatase enzyme responsible for converting androgens to estrogens, thereby

    preventing estrogen production.

     

    Breast cancer may be estrogen sensitive or insensitive. A majority of breast cancers are estrogen sensitive.

     

    Estrogen sensitive breast cancer cells depend on estrogen for viability. Thus removal of estrogen from

    the body can be an effective treatment for hormone sensitive breast cancers.

     

    Formestane has been targeted specifically for the treatment of postmenopausal women.

     

    Formestan Lentaron Specifications COA

     

    TEST ITEMS SPECIFICATION RESULTS
    Description White or Almost White Crystalline Powder white powder
    Identification A.B. Positive
    Assay 97.0~103.0% 99.3%
    Specific Rotation +101°~+105° +102.6°
    Loss On Drying 1.0%max 0.27%
    Melting Point 153~157°C 153.0~155.0°C
    Organic Volatile Impurities meets the requirement. Conforms
    Related Substances meets the requirement. Conforms
    Residual Solvents meets the requirement. Conforms
    Particle Size 100% ≤ 20 microns Conforms
    Conclusion The specification conform with USP35 standard

     

    Product name CAS Purity
    Imatinib mesylate 220127-57-1 99%
    Imatinib 152459-95-5 99%
    4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride 106261-49-8 99%
    N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine 152460-09-8 99%
    N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine 152460-10-1 99%
    Lapatinib 231277-92-2 99%
    3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate 179688-53-0 99%
    4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol 184475-71-6 99%
    7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one 199327-61-2 99%
    Erlotinib hydrochloride 183319-69-9 99%
    Erlotinib 183321-74-6 99%
    6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone 179688-29-0 99%
    4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline 183322-18-1 99%
    Sunitinib Malate 341031-54-7 99%
    Sunitinib 557795-19-4 99%
    5-Fluoro-2-oxindole 56341-41-4 99%
    5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid 253870-02-9 99%
    Ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate 2199-51-1 99%
    Diethyl 2,4-dimethylpyrrole-3,5-dicarboxylate 2436-79-5 99%
    4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid 5442-91-1 99%
    Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate 2199-59-9 99%
    N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide 356068-86-5 99%
    5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid 356068-93-4 99%
    3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline 641571-11-1 99%
    Dasatinib 302962-49-8 99%
    Dasatinib monohydrate 863127-77-9 99%
    2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302964-24-5 99%
    N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine 231278-20-9 99%
    Nilotinib 641571-10-0 99%
    4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid 641569-94-0 99%
    3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline 641571-11-1 99%
    Nilotinib hcl monohydrate 923288-90-8 99%
    Lapatinib ditosylate 388082-78-8 99%
    3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene 443882-99-3 99%
    3-Chloro-4-(3-fluorobenzyloxy)aniline 202197-26-0 99%
    Nilotinib 641571-10-0 99%
    5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde 231278-84-5 99%
    2-Formylfuran-5-boronic acid 27329-70-0 99%
    2-Aminoethylmethylsulfone hydrochloride 104458-24-4 99%
    Sorafenib tosylate 475207-59-1 99%
    Sorafenib tosylate 284461-73-0 99%
    4-(4-Aminophenoxy)-N-methylpicolinamide 284462-37-9 99%
    4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid 641569-94-0 99%
    Vandetanib 443913-73-3 99%
    Afatinib 850140-72-6 99%
    Pazopanib 444731-52-6 99%
    Dovitinib 915769-50-5 99%
    Regorafenib Hydrochloride 835621-07-3 99%
    Cinacalcet hydrochloride 364782-34-3 99%
    N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide 1005450-55-4 99%
    Ceritinib (LDK378) 1032900-25-6 99%
    4-Amino-3-fluorophenol 399-95-1 99%
    6-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one 179688-52-9 99%
    LDK-378 dihydrochloride 1380575-43-8 99%
    2,4,5-Trichloropyrimidine 5750-76-5 99%
    1-AMINO-2-(ISOPROPYLSULPHONYL)BENZENE 76697-50-2 99%
    5-Methyl-2-(1-Methylethoxy)-4- (4-piperidinyl)- BenzenaMine hydrochloride (1:2) 1380575-45-0 99%
    Osimertinib Mesylate(AZD9291) 1421373-66-1 99%
    4-Pyrimidinamine, 2,5-dichloro-N-[2-[(1-methylethyl)sulfonyl]phenyl]- 761440-16-8 99%
    4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro- 162012-67-1 99%
    (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine 314771-76-1 99%
    4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- 314771-88-5 99%
    Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]- 330792-68-2 99%
    Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- 330792-69-3 99%
    5-aMino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile 330792-70-6 99%
    5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine 330786-24-8 99%
    Intedanib 656247-17-5 99%
    Ibrutinib 936563-96-1 99%
    Axitinib 319460-85-0 99%
    Canertinib 267243-28-7 99%
    Canertinib dihydrochloride 289499-45-2 99%
    Regorafenib 755037-03-7 99%
    Mubritinib 366017-09-6 99%
    Crizotinib 877399-52-5 99%
    Alectinib 1256580-46-7 99%
    DacoMitinib 1110813-31-4 99%

     

    Our Service
    Fast Delivery Delivery within 24 hours upon receipt of your payment
    Quality Quality can be promised. Hot sell to Worldwide
    Payment Terms T/T Bank Transfer, , Bitcoin and MoneyGram Available
    Sample Sample available at any time
    Tracking your order at any time Inform your order's further new situation at any time
    Package Professional packing with professional materials

     

    566-48-3 Cancer Treatment Steroids For Breast Lentaron Formestane

    Contact Details
    SuZhou FuLu Biotech Co.,Ltd

    Contact Person: tony

    Tel: +8618115486572

    Send your inquiry directly to us (0 / 3000)